Skip to main content
. 2021 Jan 7;10:600927. doi: 10.3389/fonc.2020.600927

Figure 2.

Figure 2

Upregulating MAPK8IP1P2 inhibits cancer stem cell characteristics in thyroid cancer cells. (A) Real-time PCR analysis of MAPK8IP1P2 expression in 7 thyroid cancer cells, including 4 PTC cell lines, B-CPAP, BHT101, KTC-1, and K1, and 2 ATC cell lines, CAL-62 and 8305C, and 1 thyroid duct cell carcinoma cells, TT, and a normal thyroid follicular epithelial cell line PTFE. GAPDH was used as endogenous controls. *P < 0.05. (B) MAPK8IP1P2 expression in the vector, MAPK8IP1P2 overexpression scramble, MAPK8IP1P2 shRNA#1, and MAPK8IP1P2 shRNA#2 thyroid cancer cells using real-time PCR. Transcript levels were normalized by GAPDH expression. *P < 0.05. (C) Schematic model of lymphatic metastasis model in vivo. (D) H & E staining analysis of tumors in lymph node from the indicated mice group. (E) The count of tumor cells in the tumor areas of lymph node from the indicated mice group. *P < 0.05.